Webinar - The Future of Medical Information

Medical Information is undergoing a structural shift. Artificial intelligence is changing how healthcare professionals and patients expect to receive information. At the same time, new product categories such as GLP-1 therapies, advanced therapy medicinal products, and precision oncology treatments are driving inquiry volume and complexity upward, while regulatory expectations around MI-PV integration, traceability, and documentation continue to tighten.

For Medical Affairs and Medical Information teams, this translates into rising inquiry volumes, growing operational complexity, and increasing pressure to do more with the same, or fewer, resources.

In today's pharmaceutical environment, Medical Information is no longer a purely operational function, it is becoming a strategic one. As inquiry channels multiply and therapy types grow more complex, MI teams are expected to respond faster, stay compliant, and work more closely than ever with Pharmacovigilance.

This webinar explores how the MI function is evolving under this pressure, and what that means in practice:

• How AI is changing the way HCPs and patients access medical information, and how it is being deployed within MI operations
• Why inquiry volumes are rising, and why the current MI model may not be built to absorb that growth
• Why silos between MI and PV are becoming harder to sustain, and what integration looks like when it works

For each of these areas, we will connect what is changing in the landscape with its practical impact on inquiry handling, safety reporting, resourcing, and compliance oversight.

The session will also highlight:

• Where MI operations typically start to lose control as volume and complexity increase
• What risks emerge when handling MI enquiries around safety signal capture, documentation, and response quality
• How organizations can structure their MI function, in-house, hybrid, or outsourced, in a way that is scalable, compliant, and fit for what comes next